Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 141-151

  Douville, Renée ^a   Liu, Jiankai ^a,b   Rothstein, Jeffrey ^a   Nath, Avindra ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Basic Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TAR DNA BINDING PROTEIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; BRAIN CELL; BRAIN TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTOR CORTEX; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC DISEASE; TDP 43 PROTEINOPATHY; VIRUS EXPRESSION;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CEREBRAL CORTEX; CYTOGENETICS; ENDOGENOUS RETROVIRUSES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS;

EID: 79551480422     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22149     Document Type: Article

References (41)

1. Vucic S, Kierna MC., Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med 2009; 9: 255-272.
2. Steele AJ, Al-Chalabi A, Ferrante K, et al. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology 2005; 64: 454-458.
3. MacGowan DJ, Scelsa SN, Imperato TE, et al. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 2007; 68: 1944-1946.
4. McCormick AL, Brown RH Jr, Cudkowicz ME, et al. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 2008; 70: 278-283.
5. Verma A, Berger JR., ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006; 240: 59-64.
6. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 2000; 6: 544-548.
7. von Giesen HJ, Kaiser R, Koller H, et al. Reversible ALS-like disorder in HIV infection. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2002; 59: 474. author reply 474-475.
8. Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W., Reversible ALS-like disorder in HIV infection. Neurology 2001; 57: 995-1001.
9. Jolicoeur P., Neuronal loss in a lower motor neuron disease induced by a murine retrovirus. Can J Neurol Sci 1991; 18: 411-413.
10. Dolei A, Perron H., The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol 2009; 15: 4-13.
11. Moyes D, Griffiths DJ, Venables PJ., Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet 2007; 23: 326-333.
12. Contreras-Galindo R, Gonzalez M, Almodovar-Camacho S, et al. A new real-time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J Virol Methods 2006; 136: 51-57.
13. Medstrand P, Blomberg J., Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. J Virol 1993; 67: 6778-6787.
14. Laderoute MP, Giulivi A, Larocque L, et al. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. AIDS 2007; 21: 2417-2424.
15. Villesen P, Aagaard L, Wiuf C, Pedersen FS., Identification of endogenous retroviral reading frames in the human genome. Retrovirology 2004; 1: 32.
16. Marchler-Bauer A, Anderson JB, Chitsaz F, et al,. CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res 2009; 37: D205-D210.
17. Gopinath S, Blair IP, Kennerson ML, et al. A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36. Hum Genet 2007; 121: 559-564.
18. Sharma B, Kaushik N, Singh K, et al. Substitution of conserved hydrophobic residues in motifs B and C of HIV-1 RT alters the geometry of its catalytic pocket. Biochemistry 2002; 41: 15685-15697.
19. Berkhout B, Jebbink M, Zsiros J., Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol 1999; 73: 2365-2375.
20. Buratti E, Baralle FE., The molecular links between TDP-43 dysfunction and neurodegeneration. Adv Genet 2009; 66: 1-34.
21. Geser F, Martinez-Lage M, Kwong LK, et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol 2009; 256: 1205-1214.
22. Ou SH, Wu F, Harrich D, et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995; 69: 3584-3596.
23. Mishra M, Paunesku T, Woloschak GE, et al. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol 2007; 114: 81-94.
24. Mameli G, Astone V, Arru G, et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J Gen Virol 2007; 88: 264-274.
25. Johnston JB, Silva C, Holden J, et al. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001; 50: 434-442.
26. Perron H, Lazarini F, Ruprecht K, et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol 2005; 11: 23-33.
27. Firouzi R, Rolland A, Michel M, et al. Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol 2003; 9: 79-93.
28. Perron H, Lang A., The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol 2010; 39: 51-61.
29. Power C, McArthur JC, Nath A, et al. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998; 72: 9045-9053.
30. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60: 1094-1097.
31. Bieniasz PD., Intrinsic immunity: a front-line defense against viral attack. Nature Immunol 2004; 5: 1109-1115.
32. Garrison KE, Jones RB, Meiklejohn DA, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007; 3: e165.
33. Nakamura A, Okazaki Y, Sugimoto J, et al. Human endogenous retroviruses with transcriptional potential in the brain. J Hum Genet 2003; 48: 575-581.
34. Spadafora C., A reverse transcriptase-dependent mechanism plays central roles in fundamental biological processes. Syst Biol Reprod Med 2008; 54: 11-21.
35. Muotri AR, Chu VT, Marchetto MC, et al. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005; 435: 903-910.
36. Buzdin A, Kovalskaya-Alexandrova E, Gogvadze E, Sverdlov E., At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription. J Virol 2006; 80: 10752-10762.
37. Gogvadze E, Stukacheva E, Buzdin A, Sverdlov E., Human-specific modulation of transcriptional activity provided by endogenous retroviral insertions. J Virol 2009; 83: 6098-6105.
38. van Es MA, van Vught PW, Blauw HM, et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 2008; 40: 29-31.
39. Belshaw R, Katzourakis A, Paces J, et al. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 2005; 22: 814-817.
40. Mayer J, Meese EU., The human endogenous retrovirus family HERV-K(HML-3). Genomics 2002; 80: 331-343.
41. Bannert N, Kurth R., The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 2006; 7: 149-173.